148 related articles for article (PubMed ID: 8641368)
21. Recombinant human Flt3 ligand exerts both direct and indirect effects on hematopoiesis.
Xu Z; Xu Y; Zhu J; Shi Q; Li Y; Zhang X
Chin Med J (Engl); 2002 Feb; 115(2):202-5. PubMed ID: 11940331
[TBL] [Abstract][Full Text] [Related]
22. New cytokine-dependent acute myeloid leukemia cell line MUTZ-11 with disomic chromosome rearrangement t(16;17).
Hu ZB; Quentmeier H; Meyer C; Kaufmann M; MacLeod RA; Drexler HG
Leuk Res; 2004 May; 28(5):509-15. PubMed ID: 15068904
[TBL] [Abstract][Full Text] [Related]
23. Isolation of human mAbs that directly modulate FMS-related tyrosine kinase 3 signaling.
Yamamoto Y; Tsuzuki S; Akahori Y; Ukai Y; Sumitomo M; Murayama Y; Yamamoto K; Inaguma Y; Tokuda M; Abe A; Akatsuka Y; Emi N; Kurosawa Y
Cancer Sci; 2012 Feb; 103(2):350-9. PubMed ID: 22049994
[TBL] [Abstract][Full Text] [Related]
24. Expression of FLT3 receptor and FLT3-ligand in human leukemia-lymphoma cell lines.
Meierhoff G; Dehmel U; Gruss HJ; Rosnet O; Birnbaum D; Quentmeier H; Dirks W; Drexler HG
Leukemia; 1995 Aug; 9(8):1368-72. PubMed ID: 7643626
[TBL] [Abstract][Full Text] [Related]
25. Characterization of a t(1;19) pre-B acute lymphoblastic leukemia (ALL) cell line which proliferates in response to IL-7.
Pandrau D; Francès V; Martinez-Valdez H; Pagès MP; Manel AM; Philippe N; Banchereau J; Saeland S
Leukemia; 1993 Apr; 7(4):635-42. PubMed ID: 8464241
[TBL] [Abstract][Full Text] [Related]
26. The FLT3 tyrosine kinase receptor inhibits neural stem/progenitor cell proliferation and collaborates with NGF to promote neuronal survival.
Brazel CY; Ducceschi MH; Pytowski B; Levison SW
Mol Cell Neurosci; 2001 Oct; 18(4):381-93. PubMed ID: 11640895
[TBL] [Abstract][Full Text] [Related]
27. Antileukemic activity of Flt3 ligand in murine leukemia.
Wang A; Braun SE; Sonpavde G; Cornetta K
Cancer Res; 2000 Apr; 60(7):1895-900. PubMed ID: 10766177
[TBL] [Abstract][Full Text] [Related]
28. Establishment of a novel heterotransplantable acute lymphoblastic leukemia cell line with a t(17;19) chromosomal translocation the growth of which is inhibited by interleukin-3.
Ohyashiki K; Fujieda H; Miyauchi J; Ohyashiki JH; Tauchi T; Saito M; Nakazawa S; Abe K; Yamamoto K; Clark SC
Leukemia; 1991 Apr; 5(4):322-31. PubMed ID: 2027299
[TBL] [Abstract][Full Text] [Related]
29. Effects of FLT3 ligand on proliferation and survival of myeloid leukemia cells.
Drexler HG; Meyer C; Quentmeier H
Leuk Lymphoma; 1999 Mar; 33(1-2):83-91. PubMed ID: 10194124
[TBL] [Abstract][Full Text] [Related]
30. FLT3 inhibition in t(4;11)+ adult acute lymphoid leukaemia.
Torelli GF; Guarini A; Porzia A; Chiaretti S; Tatarelli C; Diverio D; Maggio R; Vitale A; Ritz J; Foa R
Br J Haematol; 2005 Jul; 130(1):43-50. PubMed ID: 15982343
[TBL] [Abstract][Full Text] [Related]
31. Interaction of interleukin-7 and interleukin-3 with the CXCL12-induced proliferation of B-cell progenitor acute lymphoblastic leukemia.
Juarez J; Baraz R; Gaundar S; Bradstock K; Bendall L
Haematologica; 2007 Apr; 92(4):450-9. PubMed ID: 17488655
[TBL] [Abstract][Full Text] [Related]
32. Fms-like tyrosine kinase 3 ligand stimulation induces MLL-rearranged leukemia cells into quiescence resistant to antileukemic agents.
Furuichi Y; Goi K; Inukai T; Sato H; Nemoto A; Takahashi K; Akahane K; Hirose K; Honna H; Kuroda I; Zhang X; Kagami K; Hayashi Y; Harigaya K; Nakazawa S; Sugita K
Cancer Res; 2007 Oct; 67(20):9852-61. PubMed ID: 17942916
[TBL] [Abstract][Full Text] [Related]
33. Role of interleukin-7 in the growth of acute lymphoblastic leukemia.
Touw IP; Pouwels K; van Agthoven AJ; van Gurp R; Delwel R; Hagemeijer A; Hählen K; Löwenberg B
Bone Marrow Transplant; 1990 Jul; 6 Suppl 1():36-8. PubMed ID: 2390640
[No Abstract] [Full Text] [Related]
34. In vitro culture of human acute lymphoblastic leukemia (ALL) cells in serum-free media; a comparison of native ALL blasts, ALL cell lines and virus-transformed B cell lines.
Bruserud Ø; Glenjen N; Ryningen A; Ulvestad E
Leuk Res; 2003 May; 27(5):455-64. PubMed ID: 12620297
[TBL] [Abstract][Full Text] [Related]
35. Identification of CD19(-)B220(+)c-Kit(+)Flt3/Flk-2(+)cells as early B lymphoid precursors before pre-B-I cells in juvenile mouse bone marrow.
Ogawa M; ten Boekel E; Melchers F
Int Immunol; 2000 Mar; 12(3):313-24. PubMed ID: 10700466
[TBL] [Abstract][Full Text] [Related]
36. Establishment of cell lines from B-cell precursor acute lymphoblastic leukemia.
Zhang LQ; Downie PA; Goodell WR; McCabe NR; LeBeau MM; Morgan R; Sklar J; Raimondi SC; Miley D; Goldberg A
Leukemia; 1993 Nov; 7(11):1865-74. PubMed ID: 8231254
[TBL] [Abstract][Full Text] [Related]
37. Quantitative multiparametric immunophenotyping in acute lymphoblastic leukemia: correlation with specific genotype. I. ETV6/AML1 ALLs identification.
De Zen L; Orfao A; Cazzaniga G; Masiero L; Cocito MG; Spinelli M; Rivolta A; Biondi A; Zanesco L; Basso G
Leukemia; 2000 Jul; 14(7):1225-31. PubMed ID: 10914546
[TBL] [Abstract][Full Text] [Related]
38. [Translocation (4;11) associated with mature B-line acute lymphoblastic leukemia in an adult patient].
Granada I; Ribera JM; Juncà J; Millá F; Feliu E
Sangre (Barc); 1992 Oct; 37(5):413-4. PubMed ID: 1293787
[No Abstract] [Full Text] [Related]
39. Long-term survival and proliferation of precursor-B acute lymphoblastic leukemia cells on human bone marrow stroma.
Bradstock K; Bianchi A; Makrynikola V; Filshie R; Gottlieb D
Leukemia; 1996 May; 10(5):813-20. PubMed ID: 8656676
[TBL] [Abstract][Full Text] [Related]
40. Interleukin-7 enhances colony growth and induces CD20 antigen of a Ph+ acute lymphoblastic leukemia cell line, OM9;22.
Ohyashiki K; Miyauchi J; Ohyashiki JH; Saito M; Yaguchi M; Inatomi Y; Nakazawa S; Waca H; Mizutani S; Matsuo Y
Leukemia; 1993 Jul; 7(7):1034-40. PubMed ID: 7686604
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
